Disclaimer and Test Limitation bebegene® genetic screening is tested by Eone-Diagnomics Genome Centre (EDGC), a CLIA-certified clinical lab based in South Korea with leading-edge technology for genome analysis. EDGC has a quality management system in place to ensure maximum accuracy of screening results. The test is only highly accurate for chromosomal abnormalities of aneuploidies, deletions and duplications (>200kb). As with any screening tests, false positive or false negative results cannot be completely eliminated due to various reasons including but not limited to specimen quality and other variables.
This is a genetic screening test related to the genetic predisposition developmental disorders. It cannot be considered as a diagnostic test. Hence, the risk of a disorder should never be precluded solely on the basis of screening. If pathogenic variants are detected, follow up testing is recommended to confirm the results. Signs or symptoms observed should be followed up immediately by a professional healthcare provider. Reference
1) About Autism. To be confirmed. 2) About ADHD. Website. https://www.dhcas.gov.hk/tc/adhd.html. Accessed June 18, 2020. 3) Childhood asthmas are genetically related. Hong Kong Asthma Society website. https://www.hkasthma.org.hk/hk/press-releases/926. Accessed June 18, 2020.